Bioventus Inc. (BVS)
USD 9.15
(-3.79%)
USD 9.15
(-3.79%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 409.91 Million USD | -20.11% |
| 2022 | 379.7 Million USD | 34.81% |
| 2021 | 281.65 Million USD | 33.03% |
| 2020 | 211.71 Million USD | -2.63% |
| 2019 | 217.43 Million USD | 4.72% |
| 2018 | 207.64 Million USD | 20.07% |
| 2017 | 172.93 Million USD | 2.8% |
| 2016 | 168.22 Million USD | -3.19% |
| 2015 | 173.75 Million USD | 5.0% |
| 2014 | 165.49 Million USD | -2.12% |
| 2013 | 169.07 Million USD | 0.0% |
| 1999 | 81.48 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 95.92 Million USD | 19.25% |
| 2024 Q3 | 84.89 Million USD | -11.5% |
| 2024 Q1 | 80.44 Million USD | 0.62% |
| 2023 FY | 303.34 Million USD | -20.11% |
| 2023 Q1 | 86.75 Million USD | -5.94% |
| 2023 Q2 | 80.53 Million USD | -7.17% |
| 2023 Q3 | 75.15 Million USD | -6.69% |
| 2023 Q4 | 79.94 Million USD | 6.38% |
| 2022 Q4 | 92.23 Million USD | -56.39% |
| 2022 Q1 | 96.3 Million USD | 6.19% |
| 2022 Q2 | 98.68 Million USD | 2.47% |
| 2022 FY | 379.7 Million USD | 34.81% |
| 2022 Q3 | 211.48 Million USD | 114.31% |
| 2021 FY | 281.65 Million USD | 33.03% |
| 2021 Q1 | 37.55 Million USD | -43.94% |
| 2021 Q4 | 90.69 Million USD | 16.77% |
| 2021 Q3 | 77.66 Million USD | 2.55% |
| 2021 Q2 | 75.73 Million USD | 101.66% |
| 2020 Q1 | 44.24 Million USD | -25.87% |
| 2020 FY | 211.71 Million USD | -2.63% |
| 2020 Q4 | 66.99 Million USD | 20.65% |
| 2020 Q3 | 55.53 Million USD | 23.56% |
| 2020 Q2 | 44.94 Million USD | 1.57% |
| 2019 Q3 | 50.02 Million USD | -7.64% |
| 2019 FY | 217.43 Million USD | 4.72% |
| 2019 Q2 | 54.16 Million USD | 0.0% |
| 2019 Q1 | 54.16 Million USD | 0.0% |
| 2019 Q4 | 59.69 Million USD | 19.32% |
| 2018 FY | 207.64 Million USD | 20.07% |
| 2017 FY | 172.93 Million USD | 2.8% |
| 2016 Q1 | 46.73 Million USD | 0.0% |
| 2016 FY | 168.22 Million USD | -3.19% |
| 2015 Q1 | 42.8 Million USD | 0.0% |
| 2015 FY | 173.75 Million USD | 5.0% |
| 2014 FY | 165.49 Million USD | -2.12% |
| 2013 FY | 169.07 Million USD | 0.0% |
| 1999 FY | 81.48 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -3552.156% |
| Cerus Corporation | 143.15 Million USD | -186.346% |
| OrthoPediatrics Corp. | 137.01 Million USD | -199.169% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -3508.158% |
| Talis Biomedical Corporation | 67.18 Million USD | -510.124% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -1543.221% |
| Inogen, Inc. | 236.08 Million USD | -73.632% |
| Spectral AI, Inc. | 20.86 Million USD | -1864.714% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -632.036% |
| CVRx, Inc. | 76.14 Million USD | -438.36% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -11519.004% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -3182.232% |
| Orthofix Medical Inc. | 667.42 Million USD | 38.582% |
| Venus Concept Inc. | 80.47 Million USD | -409.367% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -624.518% |
| BrainsWay Ltd. | 28.01 Million USD | -1363.052% |
| Envoy Medical, Inc. | 17.89 Million USD | -2190.301% |
| electroCore, Inc. | 32.03 Million USD | -1179.754% |
| IceCure Medical Ltd | 16.87 Million USD | -2329.0% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -866.059% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -2224.717% |
| MaxCyte, Inc. | 84.84 Million USD | -383.137% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -3202.656% |
| Nexalin Technology, Inc. | 5.78 Million USD | -6990.344% |
| PAVmed Inc | 64.82 Million USD | -532.326% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -702.533% |
| RxSight, Inc. | 103.85 Million USD | -294.721% |
| Sight Sciences, Inc. | 126.44 Million USD | -224.177% |
| SI-BONE, Inc. | 156.35 Million USD | -162.178% |
| TELA Bio, Inc. | 84.18 Million USD | -386.914% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -485.129% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | -101.568% |
| LivaNova PLC | 843.54 Million USD | 51.405% |
| 908 Devices Inc. | 68.08 Million USD | -502.112% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 15.236% |
| Nemaura Medical Inc. | 7.13 Million USD | -5642.111% |
| NeuroPace, Inc. | 75.29 Million USD | -444.409% |
| LENSAR, Inc. | 33.33 Million USD | -1129.656% |
| Apyx Medical Corporation | 51.01 Million USD | -703.477% |
| Cutera, Inc. | 197.72 Million USD | -107.318% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -1554.162% |
| BioSig Technologies, Inc. | 28.53 Million USD | -1336.796% |
| Anika Therapeutics, Inc. | 191.47 Million USD | -114.084% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -1036.767% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 50.99% |
| Axonics, Inc. | 270.2 Million USD | -51.708% |
| Outset Medical, Inc. | 198.77 Million USD | -106.227% |
| IRIDEX Corporation | 31.81 Million USD | -1188.483% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | -127.455% |
| IRadimed Corporation | 30.12 Million USD | -1260.823% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -4704.477% |
| INVO Bioscience, Inc. | 7.85 Million USD | -5119.696% |
| Telesis Bio, Inc. | 63.48 Million USD | -545.652% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -316.359% |
| Varex Imaging Corporation | 224.8 Million USD | -82.348% |
| Quipt Home Medical Corp. | 148.66 Million USD | -175.729% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -3396.699% |
| Pulmonx Corporation | 112.68 Million USD | -263.767% |
| Dynatronics Corporation | 9.9 Million USD | -4037.232% |
| Modular Medical, Inc. | 17.52 Million USD | -2238.513% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -1930.604% |
| Semler Scientific, Inc. | 38.94 Million USD | -952.583% |
| InMode Ltd. | 215.68 Million USD | -90.058% |
| Bruker Corporation | 1.07 Billion USD | 61.918% |
| Cytosorbents Corporation | 48.33 Million USD | -748.045% |
| DexCom, Inc. | 1.69 Billion USD | 75.762% |
| Align Technology, Inc. | 2.07 Billion USD | 80.262% |
| Viveve Medical, Inc. | 22.17 Million USD | -1748.726% |
| ZimVie Inc. | 275.12 Million USD | -48.993% |
| Movano Inc. | 29.69 Million USD | -1280.66% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -198.62% |
| Nexalin Technology, Inc. | 5.78 Million USD | -6990.344% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -11519.004% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 31.785% |
| Profound Medical Corp. | 33.6 Million USD | -1119.88% |
| Insulet Corporation | 939.9 Million USD | 56.387% |
| enVVeno Medical Corporation | 25.23 Million USD | -1524.21% |
| Surmodics, Inc. | 98.69 Million USD | -315.33% |
| iCAD, Inc. | 22.22 Million USD | -1744.4% |
| Nuwellis, Inc. | 22.61 Million USD | -1712.754% |
| Biotricity, Inc. | 17.18 Million USD | -2285.387% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 8.067% |
| Aethlon Medical, Inc. | 12.27 Million USD | -3238.771% |
| InspireMD, Inc. | 22.95 Million USD | -1686.135% |
| PAVmed Inc. | 64.82 Million USD | -532.326% |
| BIOLASE, Inc. | 34.66 Million USD | -1082.649% |
| Beyond Air, Inc. | 61.7 Million USD | -564.373% |
| FONAR Corporation | 28.6 Million USD | -1333.045% |
| AxoGen, Inc. | 149.33 Million USD | -174.494% |
| Vivani Medical, Inc. | 26.96 Million USD | -1420.185% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | -131.472% |
| Inari Medical, Inc. | 448.59 Million USD | 8.622% |
| UFP Technologies, Inc. | 58.08 Million USD | -605.672% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -8218.818% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -6387.801% |
| Tenon Medical, Inc. | 16.96 Million USD | -2315.83% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -5444.677% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -829.459% |
| AdaptHealth Corp. | 1.07 Billion USD | 61.973% |
| Sintx Technologies, Inc. | 15.2 Million USD | -2596.652% |
| NanoVibronix, Inc. | 4.97 Million USD | -8142.872% |
| Quanterix Corporation | 118.1 Million USD | -247.094% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -3396.699% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -2738.374% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | -4.394% |
| TransMedics Group, Inc. | 182.82 Million USD | -124.219% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -1360.602% |
| NeuroMetrix, Inc. | 11.09 Million USD | -3593.31% |
| Hyperfine, Inc. | 52.87 Million USD | -675.303% |
| Establishment Labs Holdings Inc. | 172 Million USD | -138.32% |
| Biomerica, Inc. | 6.97 Million USD | -5774.434% |
| Bone Biologics Corporation | 9.42 Million USD | -4247.739% |
| AVITA Medical, Inc. | 80.77 Million USD | -407.455% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -3875.457% |
| Silk Road Medical, Inc | 186.35 Million USD | -119.964% |